| Bioactivity | Neopanaxadiol, an aglycone of protopanaxadiol type ginsenosides, has the potential for Alzheimer's disease research[1]. |
| In Vivo | Neopanaxadiol (30 mg/kg; oral) has a T1/2 of 2.52 hours, a CL of 5.44 L/h•kg, a Cmax of 913.44 ng/mL in dogs[1]. |
| Name | Neopanaxadiol |
| CAS | 1203590-03-7 |
| Formula | C30H52O3 |
| Molar Mass | 460.73 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Cong Geng, et al. Development and validation of an UPLC-Q/TOF-MS assay for the quantitation of neopanaxadiol in beagle dog plasma: Application to a pharmacokinetic study. Biomed Chromatogr. 2017 May;31(5). |
Neopanaxadiol
CAS: 1203590-03-7 F: C30H52O3 W: 460.73
Neopanaxadiol, an aglycone of protopanaxadiol type ginsenosides, has the potential for Alzheimer's disease research.
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.